Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05178771
What this trial is testing

Efficacy of PRF Application on Clinical Parameters and GCF Platelet-derived Growth Factor-BB and Periostin Levels

Who this might be right for
Periodontitis
University of Baghdad 14
Early research (Phase 1)WithdrawnNCT01568645
What this trial is testing

Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease

Who this might be right for
Pulmonary Hypertension
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableWithdrawnNCT00907699
What this trial is testing

Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center
Not applicableStudy completedNCT05376644
What this trial is testing

Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3

Who this might be right for
Breast Cancer Female
Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590857
What this trial is testing

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Who this might be right for
Metastatic Breast CancerHER2-negative Breast CancerER+ Breast Cancer+7 more
RayzeBio, Inc. 16
Testing effectiveness (Phase 2)Looking for participantsNCT07699328
What this trial is testing

VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

Who this might be right for
EGFR-Mutant Non-Small Cell Lung Cancer
Voronoi, Inc 315
Not applicableNot Yet RecruitingNCT07815600
What this trial is testing

Pistachio Consumption in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Stages 3b-5)
Shahid Beheshti University of Medical Sciences 20
Early research (Phase 1)Study completedNCT01322802
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer

Who this might be right for
Stage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage IV Ovarian Epithelial Cancer+1 more
University of Washington 25
Not applicableStudy completedNCT03351595
What this trial is testing

Ewha Birth and Growth Study (Birth Cohort)

Who this might be right for
Pediatric HealthGrowth & DevelopmentCardiometabolic Health
Ewha Womans University 940
Testing effectiveness (Phase 2)Study completedNCT02163577
What this trial is testing

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 52
Not applicableNot Yet RecruitingNCT07427719
What this trial is testing

Retinopathy of Prematurity - Visual Function and Retinal Structure

Who this might be right for
Retinopathy of Prematurity (ROP)Prematurity ComplicationsCerebral Visual Impairment+1 more
Oslo University Hospital 140
Testing effectiveness (Phase 2)Study completedNCT01401166
What this trial is testing

Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer

Who this might be right for
Breast Neoplasms
Hoffmann-La Roche 488
Testing effectiveness (Phase 2)Ended earlyNCT01184053
What this trial is testing

Trisenox® in Women With Metastatic Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer Center 3
Not applicableStudy completedNCT00676572
What this trial is testing

P38 Mitogen-Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma

Who this might be right for
Asthma
Imperial College London 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Post-approval studies (Phase 4)WithdrawnNCT04075136
What this trial is testing

Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Who this might be right for
Exudative Age Related Macular Degeneration
Wake Forest University Health Sciences
Not applicableLooking for participantsNCT05858411
What this trial is testing

Clinical Effectiveness of Biologic Agents as an Adjunct to Non-surgical Periodontal Therapy of Intrabony Defects

Who this might be right for
Periodontal DiseasesPeriodontal Attachment LossPocket, Periodontal+1 more
G. d'Annunzio University 88
Post-approval studies (Phase 4)Study completedNCT04674254
What this trial is testing

Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic RetinopathyVascular Endothelial Growth Factor OverexpressionDiabetic Retinopathy
Cairo University 43
Not applicableNot Yet RecruitingNCT07659912
What this trial is testing

Direct Versus Video Laryngoscopy in Patients With Acromegaly

Who this might be right for
AcromegalyNonfunctioning Pituitary Adenoma
Muzaffer GENCER 40
Not applicableUnknownNCT03865628
What this trial is testing

Ultrasound Evaluation of Fetal Hemodynamics and Perinatal Complications

Who this might be right for
Intrauterine Growth RestrictionSmall-for-gestational Age
Centre Hospitalier Universitaire de Besancon 1,200
Next Page